Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ)
CNY 2.69
(-0.74%)
CNY 2.69
(-0.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 280.78 Million | 261.61 Million | 274.18 Million | 12.76 Million | 610.36 Million | 1.16 Billion |
| Net Income | 120.33 Million | -289.51 Million | 53.83 Million | 408.67 Million | -2.65 Billion | 128.77 Million |
| Depreciation & Amortization | 108.37 Million | 130.04 Million | 144.49 Million | 149.16 Million | 181.35 Million | 184.28 Million |
| Deferred income taxes | 12 Million | -9.26 Million | 4.57 Million | 120.42 Million | -35.42 Million | -52.34 Million |
| Stock-based compensation | - | - | - | 39.78 Million | - | 18.15 Million |
| Change in working capital | -65.29 Million | -24.8 Million | -23.44 Million | -167.11 Thousand | 68.35 Million | 372.27 Million |
| Other non-cash items | 320.95 Million | 445.89 Million | 99.28 Million | -705.12 Million | 3.01 Billion | 477.43 Million |
| Investing Cash Flow | 28.31 Million | -223.88 Million | 81.26 Million | 1 Billion | 70.82 Million | -167.35 Million |
| Investments in PPE | -29.62 Million | -33.01 Million | -34.51 Million | -43.66 Million | -48.42 Million | -104.33 Million |
| Acquisitions | -45.07 Million | 2.87 Million | 74.91 Million | 1.02 Billion | -340 Thousand | 23.95 Million |
| Investment purchases | -405.19 Million | -695.32 Million | -1.52 Billion | -1.3 Billion | -1.53 Billion | -852.42 Million |
| Sales/Maturities of investments | 508.2 Million | 461.51 Million | 1.55 Billion | 1.31 Billion | 1.61 Billion | 631.97 Million |
| Other Investing Activities | 124 Million | 40.05 Million | 3.04 Million | 8.34 Million | 37.33 Million | 133.48 Million |
| Financing Cash Flow | -829.7 Million | -212.54 Million | 361.58 Million | -1.65 Billion | -263.95 Million | -782.19 Million |
| Debt repayment | -785.9 Million | -1.65 Billion | -1.67 Billion | -2.98 Billion | -2.63 Billion | -2.56 Billion |
| Dividends payments | -43.8 Million | -68.76 Million | -70.93 Million | -134.48 Million | -26.37 Million | -186.62 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -43.8 Million | 1.51 Billion | 2.1 Billion | 1.46 Billion | 2.54 Billion | 1.96 Billion |
| Accounts receivables | 63.57 Million | 55.13 Million | 133.55 Million | -9.51 Million | 48.74 Million | -324.92 Million |
| Accounts payables | -97.86 Million | -191.09 Million | -183.66 Million | -138.26 Million | 99.69 Million | 731.56 Million |
| Inventory | 35.44 Million | 120.41 Million | 22.09 Million | 27.18 Million | -44.66 Million | 17.97 Million |
| Other working capital | -66.44 Million | -9.26 Million | 4.57 Million | 120.42 Million | -35.42 Million | 354.29 Million |
| Cash at beginning of period | 1.23 Billion | 1.39 Billion | 678.05 Million | 1.31 Billion | 902.31 Million | 681.31 Million |
| Cash at end of period | 711.27 Million | 1.23 Billion | 1.39 Billion | 678.05 Million | 1.31 Billion | 902.31 Million |
| Capital Expenditure | -29.62 Million | -33.01 Million | -34.51 Million | -43.66 Million | -48.42 Million | -104.33 Million |
| Effect of forex changes on cash | 987.34 Thousand | 11.92 Million | -1.57 Million | -2.85 Million | -2.16 Million | 7.78 Million |
| Net cash flow / Change in cash | -526.46 Million | -162.89 Million | 715.45 Million | -639.33 Million | 415.07 Million | 220.99 Million |
| Free Cash Flow | 251.16 Million | 228.6 Million | 239.66 Million | -30.89 Million | 561.93 Million | 1.05 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 58.51 Million | 72.68 Million | 52.28 Million | 120.33 Million | -103.28 Million | 195.37 Million |
| Depreciation & Amortization | - | 23.05 Million | 23.05 Million | 108.37 Million | 26.36 Million | -53.03 Million |
| Deferred income taxes | - | - | - | 12 Million | - | - |
| Stock-based compensation | - | 10.23 Million | - | - | - | - |
| Change in working capital | - | 12.6 Million | - | -65.29 Million | 32.57 Million | -48.53 Million |
| Other non-cash items | 43.45 Million | -1.47 Million | 106.95 Million | 320.95 Million | 96.75 Million | 10.86 Million |
| Investing Cash Flow | -3 Million | -2.59 Million | -4.75 Million | 28.31 Million | -72.89 Million | 65.47 Million |
| Investments in PPE | -10.19 Million | -10.45 Million | -13.1 Million | -29.62 Million | -11.18 Million | -5.09 Million |
| Acquisitions | -2.08 Million | 6.21 Million | 7 Million | -45.07 Million | -46.26 Million | 161.88 Thousand |
| Investment purchases | - | 152.5 Thousand | -152.5 Thousand | -405.19 Million | -36.94 Million | -77.94 Million |
| Sales/Maturities of investments | 4.85 Million | 1.5 Million | 1.5 Million | 508.2 Million | 21.5 Million | 148.35 Million |
| Other Investing Activities | 4.41 Million | 13.79 Million | 8.34 Million | 124 Million | -2.19 Million | 1.40 |
| Financing Cash Flow | -59.65 Million | -312.79 Million | -164.98 Million | -829.7 Million | -118.88 Million | -208.88 Million |
| Debt repayment | -70.5 Million | -309.96 Million | -249.89 Million | -785.9 Million | -652.99 Million | -200 Million |
| Dividends payments | -691.7 Thousand | -2.83 Million | -5.58 Million | -43.8 Million | -8.19 Million | -8.88 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | -90.48 Million | 90.48 Million | - | - | - |
| Other Financing Activities | 11.53 Million | 87.65 Million | -5.58 Million | -43.8 Million | 14.02 Million | -16.66 Million |
| Accounts receivables | - | -2.35 Million | - | 63.57 Million | 63.57 Million | -35.56 Million |
| Accounts payables | - | - | - | -97.86 Million | - | - |
| Inventory | - | 4.73 Million | - | 35.44 Million | 35.44 Million | -12.97 Million |
| Other working capital | - | 10.23 Million | - | -66.44 Million | -66.44 Million | -33.22 Million |
| Cash at beginning of period | 433.65 Million | 700.89 Million | 711.27 Million | 1.23 Billion | 936.71 Million | 975.62 Million |
| Cash at end of period | 468.53 Million | 433.92 Million | 700.89 Million | 711.27 Million | 711.27 Million | 936.53 Million |
| Capital Expenditure | -10.19 Million | -10.45 Million | -13.1 Million | -29.62 Million | -11.18 Million | -5.09 Million |
| Effect of forex changes on cash | -1.06 Million | 281.83 Thousand | 108.15 Thousand | 987.34 Thousand | -855.58 Thousand | -346.59 Thousand |
| Net cash flow / Change in cash | 34.88 Million | -266.97 Million | -10.38 Million | -526.46 Million | -225.44 Million | -39.08 Million |
| Free Cash Flow | 91.77 Million | 37.7 Million | 146.13 Million | 251.16 Million | -44.08 Million | 99.57 Million |
0881
GLP-PB
GRCU
001560
0FGL
FLO